136 related articles for article (PubMed ID: 11961879)
1. 24th Kellersberger Memorial lecture, 1999 thalidomide: will the past overshadow a promising future?
Shannon EJ
Ethiop Med J; 1999 Oct; 37(4):275-80. PubMed ID: 11961879
[No Abstract] [Full Text] [Related]
2. [Treatment of erythema nodosum leprosum using thalidomide].
Sheskin J
Acta Leprol; 1983; 1(1):41-50. PubMed ID: 6401140
[No Abstract] [Full Text] [Related]
3. Does thalidomide have a role in leprosy?
Crawford CL
Lancet; 2004 Jun; 363(9424):1911. PubMed ID: 15183644
[No Abstract] [Full Text] [Related]
4. No role for thalidomide in the treatment of leprosy.
Crawford CL
J Infect Dis; 2006 Jun; 193(12):1743-4; author reply 1744-5. PubMed ID: 16703522
[No Abstract] [Full Text] [Related]
5. Concerns regarding in vitro and in vivo uses of thalidomide.
Tadesse A; Shannon EJ
Lepr Rev; 2005 Mar; 76(1):94-6. PubMed ID: 15881041
[No Abstract] [Full Text] [Related]
6. Dose-dependent thalidomide induced bradycardia in young erythema nodosum leprosum patient.
Thangaraju P; Venkatesan S; Sivashanmugam E; Showkath Ali MK
Indian J Pharmacol; 2019; 51(1):72-74. PubMed ID: 31031470
[TBL] [Abstract][Full Text] [Related]
7. Thalidomide in the treatment of leprosy.
Teo S; Resztak KE; Scheffler MA; Kook KA; Zeldis JB; Stirling DI; Thomas SD
Microbes Infect; 2002 Sep; 4(11):1193-202. PubMed ID: 12361920
[TBL] [Abstract][Full Text] [Related]
8. Severe vasculonecrotic erythema nodosum leprosum following thalidomide withdrawal without tapering doses: do we have something unusual?
Mahajan VK; Chauhan PS; Sharma NL; Sharma AL; Mehta KS
Braz J Infect Dis; 2011; 15(1):90-1. PubMed ID: 21412598
[No Abstract] [Full Text] [Related]
9. In vitro thalidomide does not interfere with the activation of complement by M. leprae.
Shannon EJ; Sandoval FG; Morales MJ
J Drugs Dermatol; 2011 Mar; 10(3):274-8. PubMed ID: 21369644
[TBL] [Abstract][Full Text] [Related]
10. International workshop on erythema nodosum leprosum (ENL)--consensus report; the formation of ENLIST, the ENL international study group.
Walker SL; Saunderson P; Kahawita IP; Lockwood DN
Lepr Rev; 2012 Dec; 83(4):396-407. PubMed ID: 23614260
[No Abstract] [Full Text] [Related]
11. The schizophrenic career of a "monster drug".
Crawford CL
Pediatrics; 2003 Mar; 111(3):712. PubMed ID: 12612270
[No Abstract] [Full Text] [Related]
12. From the Food and Drug Administration.
Nightingale SL
JAMA; 1998 Sep; 280(10):872. PubMed ID: 9739956
[No Abstract] [Full Text] [Related]
13. Effect of oral zinc supplementation on the cell mediated immunity in lepromatous leprosy.
el-Shafei MM; Kamal AA; Soliman H; el Shayeb F; Abdel Baqui MS; Faragalla S; Sabry MK
J Egypt Public Health Assoc; 1988; 63(5-6):311-36. PubMed ID: 2979949
[No Abstract] [Full Text] [Related]
14. Preparing for thalidomide's comeback.
Vanchieri C
Ann Intern Med; 1997 Nov; 127(10):951-2. PubMed ID: 9446509
[No Abstract] [Full Text] [Related]
15. Thalidomide levels in patients with erythema nodosum leprosum.
Vieira JL; Valente Mdo S
Ther Drug Monit; 2009 Oct; 31(5):602-3. PubMed ID: 19704404
[TBL] [Abstract][Full Text] [Related]
16. Effective treatment of erythema nodosum leprosum with thalidomide is associated with immune stimulation.
Haslett PA; Roche P; Butlin CR; Macdonald M; Shrestha N; Manandhar R; Lemaster J; Hawksworth R; Shah M; Lubinsky AS; Albert M; Worley J; Kaplan G
J Infect Dis; 2005 Dec; 192(12):2045-53. PubMed ID: 16288366
[TBL] [Abstract][Full Text] [Related]
17. Deep vein thrombosis: a rare complication of thalidomide therapy in recurrent erythema nodosum leprosum.
Sharma NL; Sharma V; Shanker V; Mahajan VK; Sarin S
Int J Lepr Other Mycobact Dis; 2004 Dec; 72(4):483-5. PubMed ID: 15755204
[TBL] [Abstract][Full Text] [Related]
18. [Thalidomide used by patients with erythema nodosum leprosum].
Valente Mdo S; Vieira JL
Rev Soc Bras Med Trop; 2010; 43(2):201-4. PubMed ID: 20464154
[TBL] [Abstract][Full Text] [Related]
19. [Japanese guideline on thalidomide usage in the management of erythema nodosum leprosum].
Ishii N; Ishida Y; Okano Y; Ozaki M; Gidoh M; Kumano K; Goto M; Nogami R; Hatano K; Yamada A; Yotsu RR
Nihon Hansenbyo Gakkai Zasshi; 2011 Sep; 80(3):275-85. PubMed ID: 21941834
[TBL] [Abstract][Full Text] [Related]
20. Lack of response to WHO/MDT; a case report.
Habtemariam H; Guebre-Xabier M
Int J Lepr Other Mycobact Dis; 1993 Dec; 61(4):632-4. PubMed ID: 8151198
[No Abstract] [Full Text] [Related]
[Next] [New Search]